Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
13 juil. 2023 16h15 HE
|
Atossa Therapeutics, Inc.
SEATTLE, July 13, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical...